Summary: In a sham-controlled trial in diabetic peripheral neuropathy, adding tibial nerve neurodynamic techniques to standard rehabilitation significantly reduced neuropathy severity and improved quality of life, with some gains in pain-free range of motion, but nerve conduction did not change, indicating a symptomatic rather than structural effect.
PICO Summary
| Element | Detail |
|---|---|
| Population | 40 patients with diabetic peripheral neuropathy confirmed by electrodiagnostic and laboratory testing; randomised sham-controlled trial, Iran. |
| Intervention | Real tibial nerve neurodynamic (nerve mobilisation) techniques plus basic complementary treatment. |
| Comparison | Sham neurodynamic techniques plus the same basic treatment. |
| Outcome | The Michigan Diabetic Neuropathy Score improved with a large effect (mean difference -4.60; Cohen’s d -0.93; exceeding the minimal clinically important difference; p=0.001), and quality of life improved (mean difference -13.25; p=0.006). Nerve conduction parameters did not change. Some pain-free straight-leg-raise range-of-motion measures improved, though several were of borderline significance. |
Tibial nerve neurodynamics in diabetic neuropathy
Sham-controlled RCT · diabetic peripheral neuropathy
Adding real tibial nerve neurodynamic techniques to standard care cut neuropathy severity (MDNS) and improved quality of life versus sham, but left nerve conduction unchanged, pointing to a symptomatic rather than structural benefit.
Expert Commentary
This is a methodologically respectable trial whose sham-controlled design is its main strength, since physiotherapy studies often cannot separate a specific technique from the attention and contact of a therapist, and here the active neurodynamic technique outperformed a credible sham. The clinically meaningful result is the reduction in neuropathy severity, with a large effect size exceeding the minimal clinically important difference, alongside better quality of life, which matters because painful neuropathy is hard to treat and existing drugs offer only partial relief with side effects. The honest interpretive key, which the authors and the post both respect, is that nerve conduction did not improve, so the benefit reflects reduced mechanosensitivity and pain modulation rather than neural repair, and the range-of-motion gains were mixed with several borderline p-values. The small sample of 40, single-centre setting, and absence of long-term follow-up further temper conclusions. Can I use this with my patients? Yes, as a reasonable adjunct. For patients with painful diabetic neuropathy who cannot tolerate or wish to avoid more medication, I would consider referral to a physiotherapist trained in neurodynamic techniques, setting the honest expectation of symptom and function improvement rather than reversal of the underlying nerve damage, while keeping glycaemic control and foot care central.
References
Ashoori M, Hashemi SE, Pourahmadi M, Dadgoo M, Hosseini MS, Lotfi H, Ahmadi M. Adding tibial nerve neurodynamic techniques to a rehabilitative pain management strategy improved neuropathy severity and quality of life in patients with diabetic peripheral neuropathy: a randomized sham-controlled trial. BMC Complement Med Ther. 2025;25(1):429. doi:10.1186/s12906-025-05168-3